Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy
Related Experiment Video
Updated: Jun 19, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Woo-In Yang1, Chi Young Shim, Young Jin Kim
1Cardiology Division, Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea.
Insights
Left atrial volume index predicts adverse outcomes in hypertrophic cardiomyopathy (HCM) patients, including heart failure hospitalizations and stroke. This key metric offers valuable prognostic information for managing HCM risks.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Heart Failure Research
Background:
- Hypertrophic cardiomyopathy (HCM) can lead to sudden cardiac death and heart failure (HF).
- Predicting adverse outcomes in HCM is crucial for patient management.
- Identifying reliable prognostic markers in HCM is an ongoing clinical need.
Purpose of the Study:
- To identify predictive parameters for adverse outcomes in nonapical hypertrophic cardiomyopathy (HCM).
- To evaluate echocardiographic, cardiac magnetic resonance (CMR), and clinical markers for risk stratification.
- To determine the prognostic value of left atrial (LA) volume index in HCM.
Main Methods:
- Prospective evaluation of 81 nonapical HCM patients (51 male, mean age 57 years).
- Patients underwent cardiac magnetic resonance (CMR) and echocardiography.
- Cardiovascular events included HF hospitalization, stroke, or cardiovascular death over a mean follow-up of 41 months.
Main Results:
- Seventeen cardiovascular events occurred during follow-up.
- Univariate analysis identified age, atrial fibrillation, E/E' ratio, LA volume index, mitral regurgitation, NYHA class, and late gadolinium enhancement as associated with events.
- Multivariate analysis revealed increased LA volume index as an independent predictor of cardiovascular events (HR 1.28 per 5 mL/m(2) increase) and non-death events (HR 1.44 per 5 mL/m(2) increase).
Conclusions:
- Left atrial (LA) volume index is an independent predictor of adverse outcomes in hypertrophic cardiomyopathy (HCM).
- LA volume index provides significant additional prognostic information for HCM patients.
- This finding aids in risk stratification and management of patients with HCM.
Background:
Despite the relatively benign course for the majority of patients with hypertrophic cardiomyopathy (HCM), this disease may cause sudden cardiac death and progressive heart failure (HF). The aim of this study was to investigate useful parameters for predicting adverse outcomes of HCM, including echocardiographic parameters, cardiac magnetic resonance (CMR), and clinical markers.
Methods:
Eighty-one patients with nonapical HCM (51 men; mean age, 57 +/- 14 years) who underwent CMR and echocardiography were prospectively evaluated. Cardiovascular events were defined as hospitalization for worsening HF, stroke, or cardiovascular death.
Results:
During the mean follow-up period of 41 +/- 17 months, there were 17 cardiovascular events (5 deaths, 7 hospitalizations for worsening HF, and 5 strokes). Univariate analysis showed that older age, atrial fibrillation, elevated E/E' ratio, increased left atrial (LA) volume index, presence of mitral regurgitation grade > 2, New York Heart Association class III or IV, and late gadolinium enhancement >or= 6% were associated with cardiovascular events. In multivariate Cox regression analysis, increased LA volume index was found to be an independent predictor of cardiovascular events (for each 5 mL/m(2) increase, hazard ratio, 1.28; 95% confidence interval, 1.10-1.48; P < .01). Increased LA volume index was also revealed to be an independent predictor for cardiovascular events other than death (for each 5 mL/m(2) increase, hazard ratio, 1.44; 95% confidence interval, 1.12-1.83; P < .01).
Conclusion:
LA volume index is independently associated with adverse outcomes in patients with HCM and provides additional prognostic information.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction

